When the Trump administration announced its Most Favored Nation policy, it was portrayed as a simple, sensible idea. Drug companies were supposed to lower prices for Americans to match the lower prices paid by other nations.
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.